Leganto

Medicinal product

(Invented) name

Leganto

Active substance (s)

Rotigotinas

Strength

3 mg/24 h

Pharmaceutical form

transderminis pleistras

Route (s) of administration

vartoti per odą

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N04BC09, Rotigotine

Marketing authorisation holder

UCB Pharma S.A., Belgija

Date of authorisation

2011-06-16

Date of renewal

Documents

Search in EMA Europe

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10c

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Transdermal patch	1 vnt.
Rotigotinas	3 mg/24 h

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
47449	61266	1061266	paketėlis	N7		Receptinis	EU/1/11/695/019	Netiekiama	-	-	No	-	-
47451	61268	1061268	paketėlis	N28		Receptinis	EU/1/11/695/021	Netiekiama	-	-	No	-	-
47452	61269	1061269	paketėlis	N30		Receptinis	EU/1/11/695/022	Netiekiama	-	-	No	-	-
47455	61272	1061272	paketėlis	N84 (sudėtinė 2x42)		Receptinis	EU/1/11/695/025	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-12-13	Išregistruotas
2011-06-16	Registruotas